WallStSmart
GKOS

Glaukos Corp

NYSE: GKOS · HEALTHCARE · MEDICAL DEVICES

$135.37
+2.72% today

Updated 2026-06-05

Market cap
$7.45B
P/E ratio
P/S ratio
13.51x
EPS (TTM)
$-3.30
Dividend yield
52W range
$73 – $148
Volume
1.0M

Glaukos Corp (GKOS) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20122013201420152016201720182019202020212022202320242025
Revenue$2.43M$20.95M$45.59M$71.70M$114.40M$159.25M$181.28M$236.98M$224.96M$294.01M$282.86M$314.71M$383.48M$507.44M
Revenue growth (YoY)+762.3%+117.6%+57.3%+59.5%+39.2%+13.8%+30.7%-5.1%+30.7%-3.8%+11.3%+21.9%+32.3%
Cost of revenue$1.66M$2.54M$11.42M$12.99M$16.18M$21.05M$25.07M$38.59M$91.72M$66.63M$68.98M$75.58M$94.03M$114.23M
Gross profit$774000.00$18.41M$34.17M$58.71M$98.22M$138.20M$156.20M$198.40M$133.24M$227.38M$213.88M$239.14M$289.45M$393.22M
Gross margin31.9%87.9%75.0%81.9%85.9%86.8%86.2%83.7%59.2%77.3%75.6%76.0%75.5%77.5%
R&D$13.30M$15.51M$19.20M$25.05M$29.22M$38.91M$49.68M$68.31M$85.39M$101.00M$123.27M$138.77M$136.43M$150.61M
SG&A$8.97M$16.60M$27.73M$43.16M$63.16M$94.16M$119.53M$174.13M$169.80M$178.06M$190.43M$222.57M$259.25M$331.75M
Operating income$-22.10M$-14.20M$-13.17M$-10.30M$4.24M$-2.28M$-13.00M$-50.29M$-123.55M$-32.87M$-82.31M$-128.70M$-122.37M$-86.73M
Operating margin-909.8%-67.8%-28.9%-14.4%3.7%-1.4%-7.2%-21.2%-54.9%-11.2%-29.1%-40.9%-31.9%-17.1%
EBITDA$-21.46M$-12.76M$-8.93M$-32.96M$8.96M$5.48M$-6.74M$-37.61M$-83.59M$-1.47M$-48.76M$-82.12M$-95.64M$-146.06M
EBITDA margin-883.5%-60.9%-19.6%-46.0%7.8%3.4%-3.7%-15.9%-37.2%-0.5%-17.2%-26.1%-24.9%-28.8%
EBIT$-22.10M$-13.91M$-13.16M$-37.23M$4.24M$1000.00$-13.00M$-47.47M$-118.20M$-35.90M$-84.71M$-120.09M$-135.56M$-188.41M
Interest expense$307000.00$876000.00$1.06M$608000.00$44000.00$0.00$2.56M$14.12M$13.37M$13.72M$13.63M$10.04M$4.63M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-19.33M$-12.64M$-12.13M$-37.24M$4.52M$-92000.00$-12.95M$15.42M$-120.35M$-49.59M$-99.19M$-134.66M$-146.37M$-187.69M
Net income growth (YoY)+34.6%+4.1%-207.1%+112.1%-102.0%-13977.2%+219.1%-880.3%+58.8%-100.0%-35.8%-8.7%-28.2%
Profit margin-795.8%-60.3%-26.6%-51.9%4.0%-0.1%-7.1%6.5%-53.5%-16.9%-35.1%-42.8%-38.2%-37.0%

Frequently asked questions

What is Glaukos Corp's revenue?

Glaukos Corp's trailing twelve-month revenue is $551.35M, and consensus projects about $1.46T by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is GKOS?

In its most recent fiscal year, GKOS ran a gross margin of 77.49%, an operating margin of -17.09%, and a net margin of -36.99%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does GKOS generate?

GKOS produced $-54.01M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is GKOS's balance sheet healthy?

GKOS holds $90.81M in cash and equivalents against — in long-term debt, on $656.15M of shareholder equity. That debt is best read against the cash flow the business throws off each year.